Comparative evaluation of VITEK 2® for antimicrobial susceptibility testing of group B Streptococcus

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1109-1113

  Tazi, Asmaa ^a,b   Réglier Poupet, HélÈne ^a,b   Raymond, Josette ^a   Adam, Jean Marie ^a   Trieu Cuot, Patrick ^a,c   Poyart, Claire ^a,b,c  

^a Institut Cochin   (France)

^b INSTITUT COCHIN   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Antibiotics; Macrolides lincosamides streptogramins; PCR; Streptococcus agalactiae

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; KANAMYCIN; LINCOSAMIDE; MACROLIDE; PENICILLIN G; STREPTOGRAMIN; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN;

ACCURACY; AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DIFFUSION; GENETIC RESISTANCE; GENOTYPE; INTERMETHOD COMPARISON; LABORATORY TEST; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RELIABILITY; STREPTOCOCCUS AGALACTIAE;

AGAR; CULTURE MEDIA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; MACROLIDES; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCUS AGALACTIAE;

EID: 34447542182     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm098     Document Type: Article

References (28)

1. Schuchat A. Group B streptococcus. Lancet 1999; 353: 51-6.
2. Schrag SJ, Zell ER, Lynfield R et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347: 233-9.
3. Schrag S, Gorwitz R, Fultz-Butts K et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1-22.
4. Fitoussi F, Loukil C, Gros I et al. Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother 2001; 45: 1889-91.
5. Poyart C, Jardy L, Quesne G et al. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003; 47: 794-7.
6. Quentin R, Loulergue J, Mala L et al. Streptocoques du groupe B en pathologie humaine: Origine des isolats at sensibilité aux antibiotiques. Bull Epidemiol Hebdo 2006; 45: 352-4.
7. Gibbs RS, Schrag S, Schuchat A. Perinatal infections due to group B streptococci. Obstet Gynecol 2004; 104: 1062-76.
8. Gygax SE, Schuyler JA, Kimmel LE et al. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother 2006; 50: 1875-7.
9. Heelan JS, Hasenbein ME, McAdam AJ. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol 2004; 42: 1263-4.
10. Reference deleted.
11. Glaser P, Rusniok C, Buchrieser C et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 2002; 45: 1499-513.
12. Musser JM, Mattingly SJ, Quentin R et al. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci USA 1989; 86: 4731-5.
13. Poyart C, Celli J, Trieu-Cuot P. Conjugative transposition of Tn916 related elements from Enterococcus faecalis to Escherichia coli and Pseudomonas fluorescens. Antimicrob Agents Chemother 1995; 39: 500-6.
14. Poyart-Salmeron C, Carlier C, Trieu-Cuot P et al. Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes. Lancet 1990; 335: 1422-6.
15. Clermont D, Chesneau O, De Cespedes G et al. New tetracycline resistance determinants coding for ribosomal protection in streptococci and nucleotide sequence of tet(T) isolated from Streptococcus pyogenes A498. Antimicrob Agents Chemother 1997; 41: 112-6.
16. Khan SA, Novick RP. Complete nucleotide sequence of pT181, a tetracycline-resistance plasmid from Staphylococcus aureus. Plasmid 1983; 10: 251-9.
17. Horinouchi S, Weisblum B. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J Bacteriol 1982; 150: 815-25.
18. Comité Français de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2006. Société Française de Microbiologie, Paris, France.
19. Tang P, Ng P, Lum M et al. Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci. J Clin Microbiol 2004; 42: 2282-4.
20. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
21. Poyart C, Lamy MC, Boumaila C et al. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J Bacteriol 2001; 183: 6324-34.
22. Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 2005; 245: 195-203.
23. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-92.
24. Fines M, Gueudin M, Ramon A et al. In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin. J Antimicrob Chemother 2001; 48: 411-6.
25. Doktor SZ, Shortridge V. Differences in the DNA sequences in the upstream attenuator region of erm(A) in clinical isolates of Streptococcus pyogenes and their correlation with macrolide/ lincosamide resistance. Antimicrob Agents Chemother 2005; 49 3070-2.
26. Panagea S, Perry JD, Gould FK. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 1999; 44: 581-2.
27. Desjardins M, Delgaty KL, Ramotar K et al. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: Implications for reporting susceptibility results. J Clin Microbiol 2004; 42: 5620-3.
28. Lopardo HA, Vidal P, Jeric P et al. Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J Clin Microbiol 2003; 41: 4688-94.